
17th Panhellenic Congress of Atherosclerosis
https://ilep.eu/wp-content/movies/20221008082604_live7603_2022-10-08-07.47.08.515-UTC.mp4
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials
Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)

https://ilep.eu/wp-content/movies/20221008082604_live7603_2022-10-08-07.47.08.515-UTC.mp4

The 1st ILEP Symposium has come to an end. Finally, we are ready to share the official statistics of this event. Please see the attached

We are pleased to invite you to participate in a free webinar organized by the European Atherosclerosis Society (EAS) together with The Polish Lipid Association,

Inflammation plays a central role in the pathogenesis and clinical manifestations of atherosclerosis. Randomized controlled trials have investigated the potential benefit of colchicine in reducing

Familial hypercholesterolaemia (FH) is a genetic and complex multifactorial lipid disorder, which increases the risk of premature atherosclerosis and coronary artery disease. FH is still

Fig. 1. Direct potential causes of myocarditis. Myocarditis is an inflammatory disease of the myocardium that mostly affects young adults. The disease is commonly caused

A new paper has been published about the association of statin use in older people primary prevention group with risk of cardiovascular events and mortality.

Role of omega-6 and omega-3 fatty acids on inflammatory pathways Based on the available evidence, we are able to delineate specific nutraceuticals that may be
ILEP strongly believes in international cooperation and the power of diversity, which is why representatives of many nationalities are an essential part of our community. If you are interested in becoming part of ILEP, we invite you to complete the contact form below. Our team will be happy to provide you with more information and guide you through the next steps.
In 2025 we have been able to publish >10 papers, in which many of the ILEP members were included:
ILEP Executive Committee Meeting
Publication of ILEP meta-analysis on the role of PCSK9/ANGPTL3 inhibitors in HoFH Patients
Presentation of NEW ILEP Consensus Statements on ischemic stroke prevention at the ESC EuroStroke & EuroThrombosis in Milan with simultaneous publication in PSCVD
Presentation of the Assumption of the European Program for Prevention (EPP) with the publication on this in the Global Heart by the WHF (Nov. 2025)
10th Anniversary Congress of the International Lipid Expert Panel in Warsaw
ILEP Webinars Recommendations 2021
The 2nd Edition of ILEP Webinars starts.
ILEP hosts the 1st Edition of ILEP Webinars.
Professor Maciej Banach founds the International Lipid Expert Panel.